ISSN: 2167-065X

Pharmacologie clinique et biopharmaceutique

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Advances in Pharmacology: Exploring Novel Drug Targets and Therapeutic Strategies

Scott Kevin

Pharmacology, the study of drugs and their effects on living organisms, plays a crucial role in modern healthcare. Over the years, significant advancements have been made in understanding the mechanisms of drug action, identifying new drug targets, and developing innovative therapeutic strategies. This article highlights recent breakthroughs in pharmacology that have the potential to revolutionize medical treatments and improve patient outcomes. Advancements in genomic research and molecular biology have paved the way for precision medicine, which aims to tailor drug therapy based on an individual's unique genetic makeup. Pharmacogenomics, the study of how an individual's genetic variations influence drug response, has led to the identification of genetic biomarkers that can predict drug efficacy and adverse reactions. This personalized approach to pharmacotherapy promises optimized treatment plans and reduced side effects.